シュレーディンガー株式会社 Official site

[Live Stream 9/19 & 20] Schrödinger Digital Drug Discovery Seminar: Into the Clinic - The Transformation of the Drug Discovery Process Brought by Computational Chemistry - Sessions 4 & 5

シュレーディンガー株式会社

We would like to invite you to the 4th and 5th sessions of this seminar, where researchers involved in the Schrödinger drug discovery research project will present examples of computational chemistry drug discovery and provide an opportunity for questions and answers from the audience. ■ Theme of the 4th Session: Behind the Scenes of the Discovery of TYK2 Inhibitor Candidates Design of a Highly Selective, Allosteric, Picomolar TYK2 Inhibitor in Clinical Development Formulation ■ Theme of the 5th Session: Structure-Based Drug Discovery without a Structure Structure-Based Drug Discovery without a Structure: Enabling Accurate FEP+ Predictions for Targets and ADMET Anti-Targets with Unique Technologies and Dedicated Services ★ For more details, please check the details and registration button. * Participation from other companies in the same industry is not permitted.